Skip to main content

Senneff Steve's Form 4 filing

Signify Health, Inc. (SGFY) · filed Nov 18, 2021

Accession no.
0000950103-21-018089
Filed
Nov 18, 2021
Trade date
Nov 16-17, 2021
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions. Open-market purchases total $302.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Senneff SteveCIK 0001672957Officer (Pres. Chief Fin. & Admin. Off.)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 16, 2021Class A Common StockPPurchaseAcquired+10,000$15.32F1+$153,200122,114Direct
Nov 17, 2021Class A Common StockPPurchaseAcquired+10,000$14.92F2+$149,200132,114Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.29 to $15.38, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F2

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.77 to $15.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) to this Form 4.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)